Stockscreener 앱 받기
85.76
0.66%
0.56
시장 영업 전:
85.13
-0.63
-0.73%
Iradimed Corp 주식(IRMD)의 최신 뉴스
IRadimed Director Joe Kiani Acquires 698 Shares Through RSU Vesting on September 23, 2026 - Kalkine Media
Form 4 Iradimed Co For: 25 September By Investing.com - Investing.com Canada
698 stock units became shares for IRADIMED (NASDAQ: IRMD) director Joe E. Kiani. - Stock Titan
One-on-one investor meetings with Iradimed's CFO are set for New York - Stock Titan
Needham initiates IRadimed stock with Hold on valuation concerns By Investing.com - Investing.com Nigeria
Needham initiates IRadimed stock with Hold on valuation concerns - Investing.com
iRadimed initiated with a Hold at Needham - TipRanks
Needham Initiates IRadimed at Hold - marketscreener.com
Iradimed director Monty Allen sells $122,621 in stock By Investing.com - Investing.com Australia
Iradimed director Monty Allen sells $122,621 in stock - Investing.com
Director at IRADIMED (IRMD) sells 1,419 shares - Stock Titan
iRadimed Corp (IRMD) Stock Down 3.8% but Still Overvalued -- GF Score: 92/100 - GuruFocus
IRADIMED (NASDAQ: IRMD) director flags 1,102 RSU shares for possible sale - Stock Titan
Price to book forward of IRadimed Corp. – TRADEGATE:46K - TradingView
Rice Hall James & Associates LLC Invests $2.91 Million in iRadimed Corporation $IRMD - MarketBeat
Form 8K Iradimed Co For: 18 August By Investing.com - Investing.com UK
iRadimed (NASDAQ:IRMD) Shares Cross Below 200 Day Moving AverageTime to Sell? - MarketBeat
IRMD Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
iRadimed Corporation (NASDAQ:IRMD) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
IRadimed (IRMD) Q2 2026 Earnings Call Transcript - webull.com
iRadimed (NASDAQ:IRMD) Cut to "Hold" at Wall Street Zen - MarketBeat
Iradimed Stock Price Forecast. Should You Buy IRMD? - StockInvest.us
How IRADIMED's Modest Q2 Beat and Reaffirmed 2026 Guidance Will Impact IRMD Investors - Yahoo Finance
Replacement Cycle Anchors IRadimed Corp.’s (IRMD) Long Term Growth - Yahoo Finance
Reaffirmed 2026 Guidance and Dividend Policy Could Be A Game Changer For IRADIMED (IRMD) - simplywall.st
IRadimed Corp Earnings Call Highlights Ramp, Resilience - TipRanks
iRadimed (IRMD) Gains 1.71% as Shares Hold Above SupportTriple Bottom - dars.gov.et
iRadimed Corp (IRMD) (Q2 2026) Earnings Call Highlights: Strong Demand for New 3,870 Pump ... By GuruFocus - Investing.com Canada
IRadimed (NASDAQ:IRMD) Medical Devices Update Gains Market Attention Today - Kalkine Media
IRadimed Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
IRadimed Corp reports results for the quarter ended June 30Earnings Summary - tradingview.com
Earnings call transcript: IRadimed tops Q2 2026 estimates as 3870 ramp weighs margins - Investing.com
IRADIMED ($IRMD) Releases Q2 2026 Earnings - Quiver Quantitative
IRadimed: Q2 Earnings Snapshot - kare11.com
Iradimed reports Q2 revenue $20.5M, EPS $0.41; raises dividend to $0.20 and reaffirms 2026 guidance - TradingView
Iradimed earnings on deck as growth momentum faces Q2 test - Investing.com
Record Results, New MRI Pump And Dividend Hike Might Change The Case For Investing In IRADIMED (IRMD) - Sahm
BlackRock (IRMD holder) discloses 5.01% IRADIMED CORP stake on Schedule 13G - stocktitan.net
iRadimed (IRMD) Still Has a High-Quality Niche Story, but the Valuation Debate Is Getting Harder - AlphaStreet
Iradimed Corporation (IRMD) Sales Reflects The Fund’s Valuation and Sizing Discipline - Yahoo Finance
IRadimed Corp (IRMD) Institutional Confidence - TradingKey
IRadimed Corp (IRMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
IRadimed Corp (IRMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IRadimed Corp (IRMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IRadimed Corp (IRMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
IRadimed Corp (IRMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
IRMD|IRadimed Corp|Price:94.860|Chg%:+0.370 - TradingKey
IRadimed Corp (IRMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
IRMD|IRadimed Corp|Price:94.490|Chg%:+0.630 - TradingKey
IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026 - The Manila Times
Before market open, IRADIMED will release Q2 results July 31 - Stock Titan
iRadimed (IRMD) Expected to Post Earnings on Thursday - MarketBeat
IRADIMED CORP (IRMD) Stock Chart - ChartMill
IRADIMED (IRMD) As MRI Pump Upgrade Narrative Points To Fair Value Above The Stock - Sahm
IRADIMED CORPORATION (IRMD) Options Chain - Yahoo! Finance Canada
Iradimed Corp (IRMD) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Copeland Capital Management LLC Sells 53,225 Shares of iRadimed Corporation $IRMD - MarketBeat
iRadimed (IRMD) Q1 2026 Earnings: EPS Surprise Beats Estimates, Revenue Details Not DisclosedPeak Earnings Alert - po-news-eg.net
Price to book forward of IRadimed Corp. – LS:A118V4 - TradingView
IRMDIradimed Corp Latest SEC Filings - Finviz
Price to book forward of IRadimed Corp. – HAN:46K - TradingView
Enterprise value to EBITDA forward of IRadimed Corp. – HAN:46K - TradingView
Enterprise value to revenue forward of IRadimed Corp. – HAN:46K - TradingView
IRadimed Corp. Actuals & Estimates (DUS:46K) - TradingView
IRadimed Corp. Actuals & Estimates (NASDAQ:IRMD) - TradingView
46K Forecast — Price Target — Prediction for 2027 - TradingView
1.51%
0.97%
자본화:
|
볼륨(24시간):